STAT3 and neoplasm: Napabucasin, a small molecule inhibitor of STAT3, impairs the stemness of GSLCs by inactivating p65/RelA involved in nuclear factor-κB heterodimer formation and suppress the tumor growth in an orthotopic xenograft model [109].